Tempest Therapeutics, Inc.: 10-Q filed 2018-08-09
What Tempest Therapeutics, Inc. reported in its quarterly report filed 2018-08-09 (fiscal Q2 2018): 36 published measures, 97 facts as tagged in accession 0001544227-18-000007.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-08-09
- Fiscal period
- fiscal Q2 2018
- Accession
- 0001544227-18-000007 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Tempest Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 55,533,000 | USD | |
| At 2017-12-31 | 72,853,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 5,323,000 | USD | |
| At 2017-12-31 | 8,555,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 50,210,000 | USD | |
| At 2017-12-31 | 64,298,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 24,601,000 | USD | |
| At 2017-12-31 | 15,703,000 | USD | |
| At 2017-06-30 | 22,937,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -7,703,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -15,073,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -18,186,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -33,081,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | -13,763,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | -27,275,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 152,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 101,000 | USD | 181 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 81,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 148,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 84,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 147,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 0 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 0 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 22,660,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 6,655,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | -316,552,000 | USD | |
| At 2017-12-31 | -301,480,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 0 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 0 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 13,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 22,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 403,000 | USD | |
| At 2017-12-31 | 3,113,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 912,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 5,918,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -7,904,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -15,486,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -17,930,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -32,517,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 54,175,000 | USD | |
| At 2017-12-31 | 68,781,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 4,747,000 | USD | |
| At 2017-12-31 | 7,804,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 757,000 | USD | |
| At 2017-12-31 | 2,242,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 7,985,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 15,634,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 18,014,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 32,664,000 | USD | 181 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 54,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 166,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 274,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 543,000 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 2,645,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 6,869,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 10,751,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 17,880,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 2,394,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 5,015,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 4,997,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 10,761,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 35,789,006 | shares | |
| At 2017-12-31 | 35,725,230 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 366,735,000 | USD | |
| At 2017-12-31 | 365,769,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | -9,000 | USD | |
| At 2017-12-31 | -27,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 2,263,000 | USD | |
| At 2017-12-31 | 6,813,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 1,860,000 | USD | |
| At 2017-12-31 | 3,700,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 24,000 | USD | |
| At 2017-12-31 | 24,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 576,000 | USD | |
| At 2017-12-31 | 751,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 3,990,000 | USD | |
| At 2017-12-31 | 5,562,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 547,000 | USD | |
| At 2017-12-31 | 1,578,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -7,703,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -15,073,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -18,173,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -33,059,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -7,681,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -15,055,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -18,176,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -33,070,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 200,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 506,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 500,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 951,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -19,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 2,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 25,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -35,000 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | -1,485,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 1,101,000 | USD | 181 |
Inspect the source
- Entity
- Tempest Therapeutics, Inc. / CIK 0001544227
- Captured
- 2026-09-20T09:17:51.925Z
- SEC response SHA-256
f683ea551738b82452fd5e2664c193862efb5a386398d7ed12682e2b4be7d091
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001544227.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))